Tryton Medical, Inc., the leading developer of stents to treat bifurcation lesions, announced that the first patient has been enrolled in the EXTENDED Access Registry , a single arm study of its Tryton Side Branch Stent.
from Content Keyword RSS http://ift.tt/1pwzjww
via IFTTT
from Content Keyword RSS http://ift.tt/1pwzjww
via IFTTT
No comments:
Post a Comment